HomeTagsCAR-T Cell Therapy

CAR-T Cell Therapy

Biotechnology

Body of Evidence Grows From ZUMA-7 Study Supporting Initial Treatment

Business Wire - December 12, 2022

Kite, a Gilead Company announced findings from two new analyses of the landmark ZUMA-7 trial of Yescarta, the largest and longest follow-up of a...

Biotechnology

Regen BioPharma, Inc. Begins Experiments Validating Its Proprietary CAR-T Cell Therapy

PR Newswire - September 14, 2022

Regen BioPharma, Inc. announced initiation of a series of phased experiments to begin the process of moving its CAR-T cell de-differentiation approach through pre-clinical...

Biotechnology

IASO Bio’s Nanjing Manufacturing Facility Granted the Drug Manufacturing License for CAR-T Cell Therapy Products

PR Newswire - March 2, 2022

IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products announced that the company's commercial manufacturing...

Resilinc Announces Chris Lanier as New Chief Technology Officer

SkySafe and Fortem Partner to Enhance Drone Detection and Mitigation

Cequence Security and AWS Team Up for Advanced API Protection and…

PCS Software Appoints Danielle Villegas as Chief Product Officer

CAR-T Cell Therapy

Hot Topics

Resilinc Announces Chris Lanier as New Chief Technology Officer

SkySafe and Fortem Partner to Enhance Drone Detection and Mitigation

Cequence Security and AWS Team Up for Advanced API Protection and Bot Management